BIOCON:NSE
Biocon Ltd
₹380.15
arrow_downward
-0.48%(-1.85) 1D
Sep 16, 9:23:23 AM GMT+5:30 · INR
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for BIOCON...
Open
₹381.00
High
₹383.50
Low
₹378.35
Mkt. cap
619.20B
Avg. vol.
0.00
Volume
99.62K
Dividend
0.13%
Quarterly dividend
₹0.13
Ex-dividend date
Jul 3, 2026
P/E ratio
112.54
52-wk high
₹447.15
52-wk low
₹337.05
EPS
₹3.38
Shares outstanding
600.00M
No. of employees
16K
Open
₹381.00
High
₹383.50
Low
₹378.35
Mkt. cap
619.20B
Avg. vol.
0.00
Volume
99.62K
Dividend
0.13%
Quarterly dividend
₹0.13
Ex-dividend date
Jul 3, 2026
P/E ratio
112.54
52-wk high
₹447.15
52-wk low
₹337.05
EPS
₹3.38
Shares outstanding
600.00M
No. of employees
16K
Profile
Biocon Limited is an Indian biopharmaceutical company based in Bengaluru, with U.S. headquarters in Bridgewater, New Jersey. Founded by Kiran Mazumdar-Shaw in 1978 as a partner to the Irish brewing enzyme manufacturer Biocon Biochemicals Ltd., the company manufactures generic active pharmaceutical ingredients that are sold in approximately 120 countries, including the United States and Europe. It also manufactures novel biologics, and branded drugs such as biosimilar insulins and antibodies for the Indian domestic market. Biocon's biosimilar products are also sold in both bulk and formulation forms in several emerging markets.
Biocon's formulations for the Indian market include metabolics, oncology, immunotherapy, and nephrology products. Some of Biocon's key brands in India include INSUGEN, BASALOG, BIOMAb EGFR, BLISTO, CANMAb, Evertor, TACROGRAF, ALZUMAb and KRABEVA.
Syngene International Limited is a publicly listed subsidiary of Biocon, operating in the contract research and development organization. Wikipedia
About Biocon Ltd
CEOShreehas P Tambe
Employees16.4K
FoundedNov 29, 1978
HeadquartersBengaluru, Karnataka, India
SectorBiotechnology
Websitebiocon.com